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increased and linoleic acid is decreased in
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Background: Fatty acid (FA) composition and desaturase indices are associated with obesity and related metabolic
conditions. However, it is unclear to what extent desaturase activity in different lipid fractions contribute to obesity
susceptibility. Our aim was to test whether desaturase activity and FA composition are linked to an obese
phenotype in rats that are either obesity prone (OP) or resistant (OR) on a high-fat diet (HFD).
Methods: Two groups of Sprague–Dawley rats were given ad libitum (AL-HFD) or calorically restricted (HFD-paired;
pair fed to calories consumed by chow-fed rats) access to a HFD. The AL-HFD group was categorized into OP and
OR sub-groups based on weight gain over 5 weeks. Five different lipid fractions were examined in OP and OR rats
with regard to proportions of essential and very long-chain polyunsaturated FAs: linoleic acid (LA), alpha-linolenic
acid, eicosapentaenoic acid, docosahexaenoic acid and the stearoyl-CoA desaturase 1 (SCD-1) product 16:1n-7. FA
ratios were used to estimate activities of the delta-5-desaturase (20:4n-6/20:3n-6), delta-6-desaturase (18:3n-6/18:2n-6),
stearoyl-CoA desaturase 1 (SCD-1; 16:1n-7/16:0, SCD-16 and 18:1n-9/18:0, SCD-18), de novo lipogenesis (16:0/18:2n-6)
and FA elongation (18:0/16:0). Fasting insulin, glucose, adiponectin and leptin concentrations were measured in plasma.
Results: After AL-HFD access, OP rats had a significantly higher SCD-16 index and 16:1n-7 proportion, but a
significantly lower LA proportion, in subcutaneous adipose tissue (SAT) triacylglycerols, as well as significantly higher
insulin and leptin concentrations, compared with OR rats. No differences were found between the two phenotypes in
liver (phospholipids; triacylglycerols) or plasma (cholesterol esters; phospholipids) lipid fractions or for plasma glucose
or adiponectin concentrations. For the desaturase indices of the HFD-paired rats, the only significant differences
compared with the OP or OR rats were higher SCD-16 and SCD-18 indices in SAT triacylglycerols in OP compared with
HFD-paired rats.
Conclusion: The higher SCD-16 may reflect higher SCD-1 activity in SAT, which in combination with lower LA
proportions may reflect higher insulin resistance and changes in SAT independent of other lipid fractions. Whether a
lower SCD-16 index protects against diet-induced obesity is an interesting possibility that warrants further investigation.
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Obesity is a serious health concern that is increasing at
an unprecedented rate worldwide. Excess intake of high-
energy, highly palatable food may in turn result in a
decreased metabolic response to increased fat intake, pro-
moting a vicious cycle of weight gain [1]. However, even
when presented with a high-energy diet, not all individuals
become obese [2]. Thus, some are seemingly resistant to an
obesity-inducing environment. Understanding the under-
lying mechanisms of this phenomenon is one of the central
questions in the study of food intake regulation [3]. Just as
humans differ in their susceptibility to diet-induced
weight gain, individual animals within certain rodent
strains also show different responses to excess energy
intake [4-6]. On an ad libitum high-fat diet (HFD),
the outbred Sprague–Dawley strain of rats can be divided
into obesity-prone (OP) and obesity-resistant (OR) pheno-
types to model human diet-induced obesity (DIO) [7,8].
This two-phenotype model can be useful for elucidating
mechanisms that drive DIO, and to identify physiological
and biochemical differences between the two groups.
Compared with their OR counterparts, OP rats show a
more adverse metabolic risk profile as well as lower energy
expenditure on a HFD [9,10], and a proadipogenic expres-
sion profile [11-13]. In addition, OP rats also have lower
relative fat oxidation and fat oxidation enzyme expression
[14-17]. However, the mechanisms behind these observed
differences in DIO are still unclear, and further studies are
needed to assess other potential metabolic and biochemical
factors of importance.
Although OP/OR Sprague–Dawley rats represent key
models for the study of differential susceptibility to DIO,
the contribution of desaturase activities and fatty acid (FA)
composition in various lipid fractions to these phenotypes
has not been evaluated. Some differences in FA compos-
ition have been found between OP and OR animals, but
the data are limited to a few FAs and lipid fractions [13],
and not all desaturase indices have been studied.
Accumulating data suggest that the FA profile in plasma
and metabolic tissues associates strongly with obesity and
insulin resistance [18,19]. An altered FA metabolism and
desaturase activity have been shown to be involved in
body fat storage and oxidation [20,21]. Certain FAs and
their ratios can also be utilized as important risk markers
for various diseases and desaturase indices have been
closely linked to several obesity-related conditions [22-26].
Especially, SCD-16 and D6D have been found to correlate
positively with obesity and development of the metabolic
syndrome [19,24,27]. The desaturase indices are FA
product-to-precursor ratios that have been used to indi-
rectly calculate the activities of the enzymes responsible
for desaturating FAs [28]. By inserting double bonds into
the FA carbon chains, desaturases convert saturated into
unsaturated FAs, which in turn are substrates for variouslipids and participate in signal transduction and food
intake regulation [29,30]. The three desaturases, Δ5- (D5D),
Δ6- (D6D) and, especially, the Δ9-desaturase (also known
as stearoyl-CoA-desaturase or SCD-1), have been exten-
sively studied (for review see Bjermo & Risérus [31]).
SCD-1 is increased by saturated FAs and depressed by poly-
unsaturated FAs. Since high SCD-1 activity is associated
with decreased fat oxidation and increased FA synthesis,
and since an SCD-1 knockout leads to resistance to DIO,
SCD-1 has been proposed as a potential target in the
treatment of obesity [31,32].
Given the role for FA composition and desaturases in
pathophysiology and metabolism we aimed to investigate
these factors in response to HFD-induced weight gain.
Potential differences between the OP and OR phenotypes
in desaturase indices and biochemically important FAs,
were investigated in five lipid fractions involved in FA
handling and metabolism: subcutaneous adipose tissue
triacylglycerols (SAT-TG), liver phospholipids (liver PL),
liver triacylglycerols (liver TG), plasma cholesterol esters
(PL-CE) and plasma phospholipids (PL-PL). In order to
infer the impact of diet versus metabolic differences, we
chose to study three groups: an ad libitum HFD group of
rats divided into OP and OR, and a calorically restricted
HFD group as control.
Results
We used two dietary groups divided into a total of three ex-
perimental groups. One group of rats had ad libitum access
to a HFD (AL-HFD, n = 24); a HFD-paired group (n = 10)
were fed the HFD but were calorically restricted to follow
the weight trajectory of male Sprague–Dawley rats fed
regular chow. The rats in the AL-HFD group were further
divided into either obesity-prone (OP, n = 12) or obesity-
resistant (OP, n = 12), based on a median split of the gain in
body weight (dBw) on the HFD after the 5-week experi-
ment. There was no significant difference in initial body
weight between the three groups.
After five weeks on a HFD, the obesity-prone (220.8 ±
23.5 g; P <0.001) and obesity-resistant (167.9 ± 8.2 g; P
< 0.01) rats had gained significantly more weight than the
calorically restricted HFD-paired (133.2 ± 21.7 g) group
(Table 1). Cumulatively over the five-week period, OP rats
ate more than OR rats (P < 0.001, data not shown). Average
daily food intake was highly correlated with dBw in OP (r
= 0.87, P < 0.001) but not in OR rats (r = 0.33, P = 0.28)
(Figure 1). Food efficiency (dBw/average daily food intake
in grams) was significantly higher (P < 0.001) in OP (8.65 ±
0.43) than in OR rats (7.56 ± 0.48).
Desaturase indices in OP, OR and HFD-paired rats
Comparing the desaturase indices of OP and OR, we
found a significant difference for SCD-16 in SAT-TG, with
OP rats having a higher index than OR rats (P < 0.01)
Table 1 Body weight, food intake and fasting metabolic parameters for the three experimental groups of rats
OP OR HFD-paired
Mean SD Mean SD Mean SD
Initial BW (g)a 352.3 12.2 350.3 13.2 353. 2 16.8
Final BW (g) 573.1###, ††† 29.9 518.2‡‡ 12.3 486.4 17.3
Gain in BW (dBW) (g)a 220.8###, †† 23.5 167.9 8.2 133 21.7
Food consumption (g/day) 25.5###, ††† 2.1 22.3‡‡ 1.1 20.1 0.18
Energy consumption (kJ/day) 504.5###, ††† 40.6 441.1‡‡ 21 396.8 3.6
Insulin (μU/mL)a 127.80#, †† 34.26 79.65 31.74 87.59 52.50
Glucose (mmol/l) 6.73 0.54 6.29 0.50 6.51 0.42
Leptin (ng/mL) 22.13###, †† 5.98 15.90 4.21 11.19 3.53
Adiponectin (μg/mL) 2.32# 0.51 1.94 0.34 1.82 0.44
Body weight (BW) and food intake in obesity-prone (OP), obesity-resistant (OR) and HFD-paired rats. The symbol # indicates a significant difference between OP
and HFD-paired; † between OP and OR; ‡ between OR and HFD-paired. Level of significance: #/†/‡, P < 0.05; ##/††/‡‡, P < 0.01; ###/†††/‡‡‡, P < 0.001. All tests were
done using One-Way ANOVAs, followed by Tukey’s t-test when significant; or Kruskal Wallis test (for non-normally distributed data; indicated by a superscript “a”
where performed), followed by Dunn’s multiple comparison test when significant.
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paired rats, significant differences were detected in
SAT-TG, where SCD-16 was significantly higher in OP
compared with HFD-paired rats (P < 0.05), but no signifi-
cant difference was seen between OR and HFD-paired
rats. SAT-TG SCD-18 was significantly higher in OP com-
pared to HFD-paired rats (P < 0.01), but no difference was
detected between OR and HFD-paired rats. For all other
tested desaturase indices in SAT-TG and the four other
lipid fractions (PL-CE, PL-PL, liver PL and liver TG), no
significant differences were found between OP, OR and
HFD-paired rats.
De novo lipogenesis and elongation indices in OP, OR
and HFD-paired rats
In the initial ANOVA there was a significant difference in
the de novo lipogenesis (DNL) index of SAT-TG, which
did not however remain significant in the post-hoc test.Figure 1 Food intake was correlated with dBw only in OP rats.
Average daily food intake was highly correlated with gain in body
weight (dBw) in obesity-prone (OP; r = 0.87, P < 0.001) but not in
obesity-resistant rats (OR; r = 0.34, P = 0.28). Data analyzed using
Spearman’s rank correlation.In PL-CE, PL-PL, liver PL and liver TG there were no
significant differences for the DNL indices.
The elongation index (EI) of SAT-TG was significantly
lower in OP (P < 0.01) compared with HFD-paired rats.
In PL-PL, the EI was significantly higher in both OP (P <
0.001) and OR (P < 0.01) compared with HFD-paired rats.
In PL-CE, liver PL and liver TG, no significant differences
between the three groups were found for the EI. Results
for all the studied indices can be found in Table 2.
Fatty acid proportions in OP, OR and HFD-paired rats
In SAT-TG, 18:2n-6 (linoleic acid, LA) was found to be
significantly lower in OP compared with OR (P < 0.01)
(Figure 3) and HFD-paired rats (P < 0.05), but there was no
significant difference in LA proportions between OR and
HFD-paired rats. SAT-TG 18:3n-3 (alpha-linolenic acid,
ALA) was significantly higher in both OP and OR (P <
0.01) compared to HFD-paired rats. The product of SCD-1,
16:1n-7, was significantly higher in OP compared with OR
(P < 0.01) and HFD-paired (P < 0.05) rats. The proportion
of 22:6n-3 (docosahexaenoic acid, DHA) was significantly
higher in OP compared with HFD-paired (P < 0.05), but
not OR, rats. All FA comparisons can be found in Table 2.
In PL-CE, ALA was significantly lower in both OP and
OR compared with HFD-paired rats (P < 0.05). While
there were no differences in the 20:5n-3 (eicosapentaenoic
acid, EPA) proportion between OP and HFD-paired rats,
OR rats had a significantly lower proportion than HFD-
paired (P < 0.05). In PL-PL, DHA was significantly higher
in both OP and OR compared with HFD-paired rats (P <
0.05). In liver PL, the only significant difference was seen
for DHA, of which OR had a higher proportion than
HFD-paired rats (P < 0.01), which did not however differ
significantly from OP rats. We were not able to statisti-
cally analyze ALA in liver PL due to a lack of data. Finally,
no significant differences were found for liver TG or for
any other of the studied FAs.
Table 2 Fatty acid composition and FA enzyme indices in the three different groups of rats
SAT-TG
OP OR HFD-paired
Mean SD Mean SD Mean SD
SCD-16 0.15#, †† 0.03 0.11 0.04 0.12 0.02
SCD-18 7.6## 0.7 7.0 0.7 6.5 0.6
D6Da 2.1 *10-3 0.6 *10-3 2.3 *10-3 0.9 *10-3 2.4 *10-3 1.3 *10-3
D5D 6.5 1.2 6.3 1.3 5.7 1.3
DNL 0.94 0.06 0.89 0.06 0.88 0.05
EI 0.22## 0.02 0.24 0.04 0.27 0.03
16:1n-7 3.43#, †† 0.67 2.49 0.83 2.63 0.44
18:2n-6 24.76#, †† 1.07 25.94 0.67 25.69 0.83
18:3n-3a 1.47## 0.07 1.47‡‡ 0.12 1.35 0.05
20:5n-3 0.03 0.01 0.03 0.01 0.02 0.00
22:6n-3 0.10# 0.03 0.09 0.02 0.07 0.02
PL-CE
OP OR HFD-paired
Mean SD Mean SD Mean SD
SCD-16 0.11 0.02 0.09 0.02 0.10 0.03
SCD-18 7.7 1.2 7.9 1.5 7.8 1.8
D6D 15 *10-3 2 *10-3 14 *10-3 3 *10-3 16 *10-3 4 *10-3
D5D 271 23 277 27 248 55
DNLa 0.43 0.06 0.40 0.03 0.40 0.05
EI 0.13 0.02 0.13 0.03 0.16 0.03
16:1n-7 0.75 0.12 0.65 0.12 0.74 0.22
18:2n-6a 16.77 1.43 17.80 1.67 18.04 2.76
18:3n-3 0.13# 0.03 0.13‡ 0.03 0.17 0.04
20:5n-3 0.16 0.02 0.13‡ 0.03 0.18 0.04
22:6n-3 1.37 0.14 1.47 0.21 1.27 0.20
PL-PL
OP OR HFD-paired
Mean SD Mean SD Mean SD
SCD-16 0.012 0.002 0.011 0.003 0.011 0.003
SCD-18 0.19 0.03 0.21 0.03 0.22 0.03
D6Db 3.4 *10-3 0.8 *10-3 3.2 *10-3 0.4 *10-3 N/A N/A
D5D 43 6 45 5 39 9
DNL 0.92 0.13 0.90 0.07 0.95 0.24
EIa 1.85### 0.19 1.74‡‡ 0.24 1.53 0.061
16:1n-7 0.18 0.03 0.18 0.04 0.20 0.05
18:2n-6 17.76 2.95 18.50 1.80 20.06 3.33
18:3n-3a 0.08 0.02 0.06 0.02 0.09 0.03
20:5n-3a 0.08 0.01 0.09 0.01 0.10 0.02
22:6n-3 4.22# 0.46 4.18‡ 0.74 3.48 0.62
Liver PL
OP OR HFD-paired
Mean SD Mean SD Mean SD
SCD-16 0.013 0.004 0.011 0.003 0.011 0.004
SCD-18a 0.16 0.02 0.16 0.03 0.16 0.03
D6Da 12 *10-3 1 *10-3 11 *10-3 2 *10-3 12 *10-3 2 *10-3
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Table 2 Fatty acid composition and FA enzyme indices in the three different groups of rats (Continued)
D5Da 58 7 61 6 58 17
DNL 2.0 0.1 2.0 0.2 2.0 0.4
EI 1.9 0.1 1.9 0.2 1.7 0.1
16:1n-7 0.18 0.03 0.18 0.04 0.20 0.05
18:2n-6 7.90 0.78 7.85 1.02 8.93 1.61
20:5n-3 0.07 0.01 0.07 0.01 0.08 0.02
22:6n-3 7.84 0.96 8.51‡‡ 1.23 7.08 0.79
Liver TG
OP OR HFD-paired
Mean SD Mean SD Mean SD
SCD-16a 0.047 0.020 0.040 0.008 0.039 0.013
SCD-18 14 1 13 1 13 1
D6D 15 *10-3 2 *10-3 15 *10-3 2 *10-3 15 *10-3 2 *10-3
D5D 6.8 0.5 6.9 0.7 6.8 1.0
DNLa 1.1 0.3 1.0 0.1 1.0 0.1
EIa 0.10 0.00 0.11 0.01 0.10 0.01
16:1n-7a 1.28 0.66 1.01 0.22 1.03 0.36
18:2n-6a 25.12 2.99 25.90 1.67 26.39 2.05
18:3n-3 0.85 0.15 0.83 0.11 0.85 0.12
20:5n-3 0.18 0.06 0.17 0.04 0.17 0.03
22:6n-3a 1.15 0.43 1.16 0.42 1.02 0.35
Fatty acid (FA) composition and FA enzyme indices in five lipid fractions in obesity-prone (OP) and obesity-resistant (OR) rats with ad libitum HFD access (AL-HFD),
and energy-restricted HFD-paired rats (HFD-paired). FAs are presented as relative percentages of total FAs within each lipid fraction. The symbol # indicates a
significant difference between OP and HFD-paired; † between OP and OR; ‡ between OR and HFD-paired. Level of significance: #/†/‡, P < 0.05; ##/††/‡‡, P < 0.01;
###/†††/‡‡‡, P < 0.001. N/A, not available. All tests were done using One-Way ANOVAs, followed by Tukey’s t-test when significant; or Kruskal Wallis test (for non-
normally distributed data; indicated by a superscript “a” where performed), followed by Dunn’s multiple comparison test when significant. Where data for only
two groups was available, Student’s t-test was used (indicated by a superscript “b” where performed) for normally distributed data.
Figure 2 SCD-16 in SAT-TG increased in OP rats fed a HFD.
HFD-induced SCD-16 activity calculated from the subcutaneous
adipose tissue triacylglycerol (SAT-TG) ratio 16:1n-7/16:0. Obesity-
prone (OP) rats had a significantly higher ratio than obesity-resistant
(OR; P < 0.01) and HFD-paired (P < 0.05) rats, even after removing the
lowest value (outlier) in OR. Scatter plot lines with error bars indicate
means ± SD; data analyzed with One-way ANOVA and Tukey’s
pos-hoc test.
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HFD-paired rats
Plasma insulin and leptin concentrations were significantly
higher in OP compared with OR and HFD-paired rats, but
there were no significant differences between OR and
HFD-paired rats. No significant differences were observed
for fasting plasma glucose values. Plasma adiponectin
concentrations were significantly higher in OP compared
to HFD-paired, but not OR, rats. All glucometabolic and
adipokine values are shown in Table 1.
Discussion
In this study we examined the desaturase indices and FA
composition of two different phenotypes, OP and OR, in
five metabolically important lipid fractions in an outbred
rat model suitable for modeling human DIO. We discov-
ered a significant difference between OP and OR in the
SCD-1 index SCD-16 and the proportion of linoleic acid
in subcutaneous adipose tissue (see Figure 4 for overview),
paralleled by hormonal changes indicating an insulin re-
sistant state. Interestingly, in other lipid fractions, no sig-
nificant differences between the two phenotypes were
detected. This indicates that adipose tissue is affected early
in the development of obesity, and alterations in the FA
Figure 3 The proportion of linoleic acid in SAT-TG decreased in
OP rats fed a HFD. HFD-induced linoleic acid (18:2n-6) proportions
in subcutaneous adipose tissue triacylglycerols (SAT-TG) as relative
percentages of total fatty acids (FAs). Obesity-prone (OP) rats had a
significantly lower proportion than obesity-resistant (OR; P < 0.01)
and HFD-paired (P < 0.05) rats. Scatter plot lines with error bars
indicate means ± SD; data analyzed with One-way ANOVA and
Tukey’s post-hoc test.
Figure 4 Overview of fatty acid synthesis and HFD-induced changes b
been marked bold in orange boxes. In response to a HFD, SCD-16 and 16:1
lined red boxes), whereas LA in SAT-TG was lower in OP compared with OR r
acid; D5D, delta-5 desaturase; D6D, delta-6 desaturase; DHA, docosahexaenoic
eicosapentaenoic acid, GLA, gamma-linolenic acid; HFD, high-fat diet; LA, lino
adipose tissue triacylglycerols; SCD-1, stearoyl-CoA desaturase 1.
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pendent of those in the liver or plasma, as supported by
the observed opposing changes in the elongation index of
subcutaneous adipose tissue triacylglycerols and plasma
phospholipids.
Our results help to further elucidate the role that
SCD-1 plays in driving susceptibility to diet-induced
obesity, as it has not yet been determined whether diffe-
rences in SCD-1 between OP and OR rats exist in the
adipose tissue and whether these changes occur simul-
taneously across lipid fractions. It has previously been
found that a HFD, especially a diet rich in SFA,
decreases SCD expression in both rat liver and adipose
tissue [33,34]. A HFD has also been shown to decrease
the index SCD-16 in adipose tissue in a sex-independent
manner [35]. Another study has instead shown that SFA
are essential for increasing SCD-1 in mice [36], perhaps
by counteracting the effect of PUFAs [37]. Human inter-
vention studies have also reported increased SCD-16 on
a SFA-rich diet [38]. It has also been found that hepatic
SCD-1 levels are higher in OP versus OR rats [13] and
OP versus OR mouse strains [39]. These diverging
results may be due to differences in e.g. study design,
diet, animal species and tissue investigated.etween OP and OR rats. Studied fatty acid (FA) indices and FAs have
n-7 in SAT-TG was higher in OP compared with OR rats (dashed bold-
ats (solid bold-lined green box). AA, arachidonic acid; ALA, alpha-linolenic
acid; DPA, docosapentaenoic acid; DTA, docosatetraenoic acid; EPA,
leic acid; OP, obesity-prone; OR, obesity-resistant; SAT-TG, subcutaneous
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might reflect a genetically inherent difference in FA meta-
bolism pathways that, at least at an early point in DIO, is
only found in this specific tissue. In a previous study we
found a genetic variant of the SCD-1 gene to be associated
with the degree of abdominal obesity and insulin sensitivity
in elderly men [40]. In DIO, OP rats may induce SCD-1 to
protect them from excess SFA storage. In this case,
increased SCD-1 could perhaps be used as a marker for
increased fat preference and fat intake. Interestingly, a
protective role for SCD-1 could be supported by our
finding that the SCD-1 product palmitoleic acid (16:1n-7)
was higher in the SAT-TG in OP compared with OR rats,
as this FA has been reported to serve as an insulin-
sensitizing lipokine in the adipose tissue [41]. Alternatively,
OR rats may downregulate SCD-1, to prevent adipose tis-
sue storage of FAs and promote oxidation, which may be
increased in OR rats [13,14]. If SCD-1 downregulation is
protective against DIO, a higher activity could imply that
such protective pathways are genetically dysregulated in
OP animals. It has been shown that loss of SCD-1 both
prevents obesity [19,42,43] and reduces inflammation in
adipocytes [44]. A possible target in DIO could therefore
be to selectively downregulate SCD-1 in adipose tissue,
since a global knock-down of SCD-1 has been shown to
lead to deleterious effects [4].
The non-uniform changes in SCD-16 activity across
lipid fractions in this study, could be due to differences
in species, strain and experimental duration: Li et al.
used Wistar rats exposed to a 16-week HFD – notably
longer than our 5-week treatment, which may therefore
reflect earlier changes – while Hu et al. fed obesity-
prone (C57BL/6) and obesity-resistant (FVB) mouse
strains a HFD for 8 weeks [13,39]. Both of the aforemen-
tioned studies examined SCD-1 mRNA expression,
whereas we studied the indices SCD-16 and SCD-18. In
our study, the lack of difference in SCD-18, an index
also employed to reflect SCD-1 enzyme activity, could
be due to the high dietary content of the SCD-18 pro-
duct oleic acid (OA; 18:1n-9), which could influence the
SCD-18 index [31]. At least in our DIO model, the adi-
pose tissue may be one of the first tissues affected by
DIO. This was evident as an altered FA metabolism with
up-regulated SCD-1 activity index and decreased linoleic
acid proportions in OP rats. Changes in the liver, such
as those observed in other studies, might then follow as
insulin-resistance worsens. This further highlights the
importance of the adipose tissue as a key metabolic
tissue involved in the development of obesity.
We also found that OP rats had a significantly lower
proportion of linoleic acid in SAT-TG, both compared
to OR and the calorically restricted rats. Low propor-
tions of LA in humans have previously been found in
plasma of obese subjects [27]. In adipose tissue of oldermen, LA has recently been weakly but positively correlated
with insulin sensitivity [45]. Intervention studies suggest
that LA-rich diets may decrease SAT and improve insulin
sensitivity [46], in line with a possible anti-diabetic effect
of LA [47] that should be further investigated.
The higher SCD-1 in OP compared with OR rats could
be due to the higher insulin levels seen in the OP rats, as
insulin is known to regulate SCD-1 transcription [42,48].
Such interpretation is on the other hand complicated by
the elevated leptin concentrations observed in OP rats, as
leptin has been shown to decrease both hepatic and
adipose tissue SCD-1 expression [49,50]. No difference in
adiponectin levels were however found between OP and
OR rats. We however did find that plasma adiponectin
levels were higher in OP compared with HFD-paired rats,
which may be due to an increased adiponectin resistance
in OP compared with HFD-paired rats, with an at least ini-
tial compensatory higher adiponectin production [51-54].
OP but not OR rats showed a correlation between
food intake and dBw. This strengthens the notion that
OR rats have biochemical differences rendering them less
efficient at converting food into fat tissue. This difference
could perhaps simply be caused by a greater genetic
heterogeneity within the OR group. It has however been
discovered that on a HFD, OR rats seem to have a propor-
tionately higher fat oxidation [14], and that OR in male
but not female rats is associated with better food intake
control [9]. Furthermore, a transcriptomic analysis previ-
ously found that OP rats have differences in metabolic
pathways involving the Krebs cycle, increased ketone body
production and a cholesterol transfer promoting fat
storage [13]. Our finding that OR rats had a lower food
efficiency than OP rats is supported by the findings
reported by Chang et al. [14]. The two phenotypes seen in
this study therefore seem to present two other major
differences: a reduced food intake in OR rats, possibly due
to a more optimal reward system [55], and a reduced food
efficiency, perhaps linked to lower SCD-1 activity or other
biochemical differences in the handling of FAs.
Since we had a control group that was calorically
restricted but fed an identical HFD as the one fed ad
libitum to the OP and OR groups, we could evaluate
the effects of both ad libitum HFD intake and obesity
phenotype on FA metabolism. The SCD-16 index of
the SAT-TG was significantly higher in OP rats compared
with the energy-restricted HFD-paired rats, whereas there
was no difference between the OR and HFD-paired rats.
Thus, even after moderate weight gain and ad libitum
access to the HFD, the OR rats seem to be metabolically
similar to the HFD-paired rats. However, for most of
the desaturase indices and FAs no differences were
observed when ad-libitum-fed rats were compared with
the calorically restricted rats, suggesting that on a HFD,
many of these parameters are weight-independent.
Table 3 Dietary composition of the experimental diet
Composition by weight (g/kg)
Casein, 80 Mesh 233
L-Cystine 3.5
Corn Starch 84.8
Maltodextrin 116.5
Sucrose 201.4
Cellulose, BW200 58.3
Soybean Oil 29.1
Lard 206.8
Mineral Mix S10026 11.7
DiCalcium Phosphate 15.1
Calcium Carbonate 6.4
Potassium Citrate, 1 H2O 19.2
Vitamin Mix V10001 11.7
Choline Bitartrate 2.3
FD&C Red Dye #40 0.06
FA profile (% of total FAs)
Saturated 36.3
Monounsaturated 45.3
Polyunsaturated 18.5
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more than often differ between different studies [21],
thus complicating comparisons between studies. The FA
composition of the diet could mask potential differences
in FA composition between OP and OR rats that would
have been seen if the animals had been given a different
diet. However, on the other hand, both the calorie-
restricted and the ad libitum groups received the same
diet, making the results more attributable to metabolic
differences. To elucidate what drives the OP and OR
phenotypes, initial measurements of the FA composition
would have been valuable. Such data could have pro-
vided additional predictive markers for susceptibility to
DIO; some of which, e.g. plasma-derived FA, could be
easily measurable in human subjects. E.g. SCD-1 is
known to be correlated with markers of obesity [27], but
it is still unknown whether these pathological changes
are caused by SCD-1 per se, or if it is a marker of or per-
haps even a compensatory mechanism for these ongoing
processes [31]. Furthermore, the adipose tissue analyzed
herein was derived from the inguinal fat depot, and does
not necessarily reflect other adipose tissue depots, as
reported by other researchers [35,56].
Conclusion
In this experiment we demonstrate that obesity-prone
rats have a significantly higher SCD-16 index, signifi-
cantly higher proportions of the SCD-1 product 16:1n-7,
but a lower proportion of LA in adipose tissue. These
changes are largely independent of weight gain and seem
to appear before any changes in the plasma or liver tissue,
and are paralleled by hormonal changes indicating insulin
resistance with possible compensatory changes. Whether a
lower SCD-16 index protects against DIO is an interesting
possibility that warrants further investigation.
Methods
Thirty-four male outbred Sprague–Dawley rats (Scanbur
B&K, Sollentuna, Sweden) were used in this study. At
the start of the experiments the rats were 8 weeks old
and weighed 352 ± 12 g (mean ± SD). The rats were
housed one per cage, in standard macrolon cages (type
IV), which had a wood chip bedding and a wooden
house as enrichment. All rats had free access to water.
Ambient temperature (21-22°C) and humidity (40–50%)
were kept constant and a 12-h-light cycle with lights on
at 07:00 was used. The rats were allowed one week of
adaptation to the animal facility conditions before onset
of the experiments. The rats were then randomly divided
into two dietary groups. One group of rats were fed a
HFD ad libitum (AL-HFD, n = 24); the control group
(HFD-paired, n = 10) were fed the HFD but were caloric-
ally restricted to follow the weight trajectory of male
Sprague–Dawley rats with ad libitum access to regularchow. The HFD (D12451, ResearchDiets) contained 19.79
kJ (4.73 kcal)/g (20% protein, 35% carbohydrates and 45%
fat by energy; see Table 3 for composition). During the five
weeks of access to the diets, food intake and body weight
were measured daily during the first week and thereafter
three times a week. After the five-week dietary intervention,
the rats were fasted for three hours and were then killed by
decapitation, at which point trunk blood was collected.
Plasma was isolated by centrifugation and stored at −80°C
until analyzed. Liver tissue and subcutaneous adipose tissue
(SAT) from the inguinal region were isolated and stored at
−80°C. Note that data from a subset of these rats have pre-
viously been analyzed and published [56].
Analysis of fatty acid composition
Gas chromatography was used as previously described
by Boberg et al. [57] to analyze the FA composition
of five different lipid fractions: subcutaneous adipose
tissue triacylglycerols (SAT-TG), plasma cholesterol
esters (PL-CE), plasma phospholipids (PL-PL), liver
phospholipids (liver PL) and liver triacylglycerols
(liver TG).
For the SAT and liver tissue, each tissue (5-25 mg of
SAT; 40–50 mg of liver tissue) was extracted in 2.5 ml
methanol and 5.0 ml chloroform (containing 0.005%
butylated hydroxytoluene as an antioxidant). 7.5 ml
0.2 mol/l sodium dihydrogen phosphate (Na2H2PO4)
was added and the extract was left at +4°C over night.
Both the liver and SAT chloroform phases were evapo-
rated to dryness under nitrogen. The SAT lipid esters
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2 ml of 5% H2SO4 in methanol.
For lipid extraction from plasma, 2.5 ml of methanol
was added to 0.5 ml of plasma. After thorough mixing of
the extract, 5.0 ml Chloroform (containing 0.005% buty-
lated hydroxytoluene as an antioxidant) and 7.5 ml of
0.2 mM sodium dihydrogen phosphate (Na2H2PO4) were
added and were left at + 4°C over night. The chloroform
phase was evaporated to dryness under nitrogen and the
lipid residue was dissolved in 200–300 μl chloroform.
For the plasma and liver lipid fractions, the lipid esters
(triacylglycerols and phospholipids from liver; cholesterol
esters and phospholipids from plasma) were separated by
thin-layer chromatography (TLC). The chloroform solu-
tion was applied to the adsorbent (Silica gel 60G, Merck)
containing POPOP as a fluorescent agent. The TLC plates
were eluted at room temperature with the solvent system
petroleum benzine/diethyl ether/acetic acid (81:18:1, by
vol). The lipid fractions were visualized in UV light and
the spots were scraped off into vials and the lipid esters
were transmethylated at 60°C overnight after addition of 2
ml 5% H2SO4 in methanol.
For all five lipid fractions, the methyl esters were
extracted into 3 ml of petroleum ether containing 0.005%
butylated hydroxytolvene after addition of 1.5 ml distilled
water. The phases were separated after thorough mixing
and centrifugation at 1500 × g for 10 min. The petroleum
ether phase was pipetted off and the solvent was evapo-
rated under nitrogen. The methyl esters were then redis-
solved in Uvasol, grade hexane.
The FA methyl esters from the five different fractions
were separated by gas chromatography (GC) on a 30-m
glass capillary column coated with Thermo TR-FAME
(Thermo Electron Corporation, USA), with helium gas as a
carrier gas. An Agilent Technologies system consisting of
model GC 6890N, autosampler 7683 and Agilent Chem-
Station was used. The temperature was programmed to
150–260°C. The FAs were identified by comparing each
peak’s retention time with FA methyl ester standard Nu
Check Prep (Elysian, MN, USA) and are expressed as rela-
tive percentages of total FAs. Due to low proportions, not
all FAs were quantifiable in all samples.
Glucometabolic and adipokine analyses
Plasma insulin and glucose were analyzed with vali-
dated in-house methods, whereas plasma adiponectin
and leptin were measured with RIA kits according to
the manufacturer's instructions (Millipore AB, Solna,
Sweden).
Statistical analyses
To minimize the number of statistical tests, we chose to
limit our statistical tests of FAs to the indices for desa-
turases (SCD-16 (16:1n-7/16:0), SCD-18 (18:1n-9/18:0),D6D (18:3n-6/18:2n-6), D5D (20:4n-6/20:3n-6), de novo
lipogenesis (DNL; 16:0/18:2n-6) and elongation (EI, 18:0/
16:0), and important polyunsaturated FAs with bioactive
properties, i.e. essential n-6 (18:2n-6, LA), and n-3 (18:3n-3,
ALA) FAs as well as very long chain n-3 FAs (20:5n-3, EPA;
22:6n-3, DHA). We also investigated the proportions of the
SCD-16 product, 16:1n-7 (palmitoleate), since 16:1n-7 has
been proposed as an adipokine [41].
GraphPad Prism v 5.02 (GraphPad Software Inc., San
Diego, CA) was used for all statistical calculations.
Kolmogorov-Smirnov’s test of normality was first used
to determine whether data was normally distributed.
The following parameters were found to be non-
normally distributed in OP rats: SAT-TG D6D; PL-CE
DNL index and EI; liver PL SCD-18, D6D and D5D; and
liver TG SCD-16, DNL index, EI, 16:1n-7, and LA. In OR
rats the non-normally distributed parameters were: dBw;
SAT-TG D6D; PL-CE LA; and PL-PL EI. In HFD-paired
rats the non-normally distributed parameters were: initial
body weight; plasma insulin concentrations; SAT-TG D6D
and ALA; PL-PL ALA and EPA; and liver TG DHA. To de-
tect differences between the three different groups, the
investigated normally and non-normally distributed para-
meters were analyzed using, respectively, One-way ANOVA
or Kruskal-Wallis ANOVA. For significant ANOVAs, we
proceeded with post-hoc tests to find significant group dif-
ferences: for One-way ANOVA, Tukey’s test was used; for
Kruskal-Wallis, Dunn’s test was used. When only two
groups were compared, the Student’s t-test was used for
normally distributed data. For correlations, non-normally
distributed data was analyzed using Spearman’s rank
correlation. Values were considered significant at the
P < 0.05 level and are presented as means ± SD.
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